nodes	percent_of_prediction	percent_of_DWPC	metapath
Saxagliptin—ABCC1—Dactinomycin—kidney cancer	0.101	0.146	CbGbCtD
Saxagliptin—CYP3A5—Temsirolimus—kidney cancer	0.0779	0.113	CbGbCtD
Saxagliptin—ABCC1—Paclitaxel—kidney cancer	0.0721	0.104	CbGbCtD
Saxagliptin—ABCC1—Vinblastine—kidney cancer	0.0633	0.0915	CbGbCtD
Saxagliptin—ABCC1—Vincristine—kidney cancer	0.0622	0.09	CbGbCtD
Saxagliptin—CYP3A4—Everolimus—kidney cancer	0.045	0.0651	CbGbCtD
Saxagliptin—ABCC1—Doxorubicin—kidney cancer	0.0389	0.0562	CbGbCtD
Saxagliptin—CYP3A4—Temsirolimus—kidney cancer	0.0304	0.044	CbGbCtD
Saxagliptin—CYP3A5—Erlotinib—kidney cancer	0.0292	0.0423	CbGbCtD
Saxagliptin—CYP3A5—Paclitaxel—kidney cancer	0.0267	0.0387	CbGbCtD
Saxagliptin—CYP3A5—Sorafenib—kidney cancer	0.0238	0.0344	CbGbCtD
Saxagliptin—CYP3A5—Vincristine—kidney cancer	0.0231	0.0334	CbGbCtD
Saxagliptin—CYP3A5—Sunitinib—kidney cancer	0.0192	0.0278	CbGbCtD
Saxagliptin—CYP3A4—Pazopanib—kidney cancer	0.016	0.0231	CbGbCtD
Saxagliptin—CYP3A4—Erlotinib—kidney cancer	0.0114	0.0165	CbGbCtD
Saxagliptin—CYP3A4—Paclitaxel—kidney cancer	0.0104	0.0151	CbGbCtD
Saxagliptin—CYP3A4—Sorafenib—kidney cancer	0.00926	0.0134	CbGbCtD
Saxagliptin—CYP3A4—Vinblastine—kidney cancer	0.00915	0.0132	CbGbCtD
Saxagliptin—CYP3A4—Vincristine—kidney cancer	0.00899	0.013	CbGbCtD
Saxagliptin—SLC22A8—nephron—kidney cancer	0.00803	0.11	CbGeAlD
Saxagliptin—CYP3A4—Sunitinib—kidney cancer	0.00751	0.0109	CbGbCtD
Saxagliptin—SLC22A8—urine—kidney cancer	0.00644	0.0882	CbGeAlD
Saxagliptin—DPP8—nephron tubule—kidney cancer	0.00627	0.0859	CbGeAlD
Saxagliptin—CYP3A4—Doxorubicin—kidney cancer	0.00562	0.00813	CbGbCtD
Saxagliptin—DPP8—cortex of kidney—kidney cancer	0.00537	0.0736	CbGeAlD
Saxagliptin—DPP8—cardiac atrium—kidney cancer	0.00511	0.07	CbGeAlD
Saxagliptin—SLCO4C1—nephron tubule—kidney cancer	0.00397	0.0544	CbGeAlD
Saxagliptin—SLCO4C1—renal system—kidney cancer	0.00361	0.0494	CbGeAlD
Saxagliptin—SLCO4C1—kidney—kidney cancer	0.00349	0.0478	CbGeAlD
Saxagliptin—SLCO4C1—cortex of kidney—kidney cancer	0.0034	0.0465	CbGeAlD
Saxagliptin—CYP3A4—urine—kidney cancer	0.00319	0.0437	CbGeAlD
Saxagliptin—DPP4—nephron tubule—kidney cancer	0.00263	0.0361	CbGeAlD
Saxagliptin—DPP4—renal system—kidney cancer	0.0024	0.0328	CbGeAlD
Saxagliptin—DPP4—kidney—kidney cancer	0.00232	0.0317	CbGeAlD
Saxagliptin—DPP4—cortex of kidney—kidney cancer	0.00226	0.0309	CbGeAlD
Saxagliptin—SLC22A8—nephron tubule—kidney cancer	0.00173	0.0237	CbGeAlD
Saxagliptin—SLC22A8—renal system—kidney cancer	0.00158	0.0216	CbGeAlD
Saxagliptin—SLC22A8—kidney—kidney cancer	0.00152	0.0209	CbGeAlD
Saxagliptin—SLC22A8—cortex of kidney—kidney cancer	0.00148	0.0203	CbGeAlD
Saxagliptin—ABCC1—cortex of kidney—kidney cancer	0.00128	0.0175	CbGeAlD
Saxagliptin—ABCC1—cardiac atrium—kidney cancer	0.00121	0.0166	CbGeAlD
Saxagliptin—CYP3A5—nephron tubule—kidney cancer	0.00114	0.0157	CbGeAlD
Saxagliptin—CYP3A5—renal system—kidney cancer	0.00104	0.0143	CbGeAlD
Saxagliptin—CYP3A5—kidney—kidney cancer	0.00101	0.0138	CbGeAlD
Saxagliptin—CYP3A5—cortex of kidney—kidney cancer	0.00098	0.0134	CbGeAlD
Saxagliptin—CYP3A4—renal system—kidney cancer	0.000781	0.0107	CbGeAlD
Saxagliptin—CYP3A4—kidney—kidney cancer	0.000755	0.0103	CbGeAlD
Saxagliptin—Angioedema—Sunitinib—kidney cancer	0.000428	0.00205	CcSEcCtD
Saxagliptin—Oedema peripheral—Gemcitabine—kidney cancer	0.000425	0.00203	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000419	0.00201	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000417	0.00199	CcSEcCtD
Saxagliptin—Asthenia—Pazopanib—kidney cancer	0.000415	0.00199	CcSEcCtD
Saxagliptin—Arthralgia—Sorafenib—kidney cancer	0.000414	0.00198	CcSEcCtD
Saxagliptin—Myalgia—Sorafenib—kidney cancer	0.000414	0.00198	CcSEcCtD
Saxagliptin—Face oedema—Capecitabine—kidney cancer	0.000413	0.00198	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000411	0.00197	CcSEcCtD
Saxagliptin—Pruritus—Pazopanib—kidney cancer	0.00041	0.00196	CcSEcCtD
Saxagliptin—Dizziness—Temsirolimus—kidney cancer	0.000406	0.00194	CcSEcCtD
Saxagliptin—Dyspepsia—Everolimus—kidney cancer	0.000402	0.00193	CcSEcCtD
Saxagliptin—Infestation—Paclitaxel—kidney cancer	0.000402	0.00192	CcSEcCtD
Saxagliptin—Infestation NOS—Paclitaxel—kidney cancer	0.000402	0.00192	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000402	0.00192	CcSEcCtD
Saxagliptin—Blood creatinine increased—Capecitabine—kidney cancer	0.000401	0.00192	CcSEcCtD
Saxagliptin—Arthralgia—Sunitinib—kidney cancer	0.000398	0.00191	CcSEcCtD
Saxagliptin—Myalgia—Sunitinib—kidney cancer	0.000398	0.00191	CcSEcCtD
Saxagliptin—Anaphylactic shock—Sorafenib—kidney cancer	0.000397	0.0019	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000396	0.00189	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Everolimus—kidney cancer	0.000395	0.00189	CcSEcCtD
Saxagliptin—Infection—Sorafenib—kidney cancer	0.000394	0.00189	CcSEcCtD
Saxagliptin—Fatigue—Everolimus—kidney cancer	0.000394	0.00189	CcSEcCtD
Saxagliptin—Urinary tract infection—Paclitaxel—kidney cancer	0.000391	0.00187	CcSEcCtD
Saxagliptin—Vomiting—Temsirolimus—kidney cancer	0.000391	0.00187	CcSEcCtD
Saxagliptin—Immune system disorder—Gemcitabine—kidney cancer	0.00039	0.00186	CcSEcCtD
Saxagliptin—Thrombocytopenia—Sorafenib—kidney cancer	0.000389	0.00186	CcSEcCtD
Saxagliptin—Dyspepsia—Erlotinib—kidney cancer	0.000388	0.00186	CcSEcCtD
Saxagliptin—Rash—Temsirolimus—kidney cancer	0.000388	0.00185	CcSEcCtD
Saxagliptin—Dermatitis—Temsirolimus—kidney cancer	0.000387	0.00185	CcSEcCtD
Saxagliptin—Skin disorder—Sorafenib—kidney cancer	0.000385	0.00184	CcSEcCtD
Saxagliptin—Headache—Temsirolimus—kidney cancer	0.000385	0.00184	CcSEcCtD
Saxagliptin—Nasopharyngitis—Capecitabine—kidney cancer	0.000383	0.00183	CcSEcCtD
Saxagliptin—Dizziness—Pazopanib—kidney cancer	0.000383	0.00183	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000381	0.00182	CcSEcCtD
Saxagliptin—Fatigue—Erlotinib—kidney cancer	0.00038	0.00182	CcSEcCtD
Saxagliptin—Infection—Sunitinib—kidney cancer	0.000379	0.00182	CcSEcCtD
Saxagliptin—Gastritis—Capecitabine—kidney cancer	0.000379	0.00181	CcSEcCtD
Saxagliptin—Sinusitis—Paclitaxel—kidney cancer	0.000377	0.00181	CcSEcCtD
Saxagliptin—Myalgia—Dactinomycin—kidney cancer	0.000377	0.0018	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Vinblastine—kidney cancer	0.000375	0.0018	CcSEcCtD
Saxagliptin—Thrombocytopenia—Sunitinib—kidney cancer	0.000374	0.00179	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Everolimus—kidney cancer	0.000374	0.00179	CcSEcCtD
Saxagliptin—Skin disorder—Sunitinib—kidney cancer	0.000371	0.00177	CcSEcCtD
Saxagliptin—Vomiting—Pazopanib—kidney cancer	0.000368	0.00176	CcSEcCtD
Saxagliptin—Rash—Pazopanib—kidney cancer	0.000365	0.00175	CcSEcCtD
Saxagliptin—Nausea—Temsirolimus—kidney cancer	0.000365	0.00175	CcSEcCtD
Saxagliptin—Dermatitis—Pazopanib—kidney cancer	0.000365	0.00175	CcSEcCtD
Saxagliptin—Abdominal pain—Vinblastine—kidney cancer	0.000363	0.00174	CcSEcCtD
Saxagliptin—Headache—Pazopanib—kidney cancer	0.000363	0.00174	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000362	0.00173	CcSEcCtD
Saxagliptin—Abdominal pain—Everolimus—kidney cancer	0.000361	0.00173	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Erlotinib—kidney cancer	0.000361	0.00173	CcSEcCtD
Saxagliptin—Infection—Dactinomycin—kidney cancer	0.000359	0.00172	CcSEcCtD
Saxagliptin—Oedema peripheral—Paclitaxel—kidney cancer	0.000356	0.0017	CcSEcCtD
Saxagliptin—Thrombocytopenia—Dactinomycin—kidney cancer	0.000354	0.00169	CcSEcCtD
Saxagliptin—Dyspepsia—Sorafenib—kidney cancer	0.000349	0.00167	CcSEcCtD
Saxagliptin—Abdominal pain—Erlotinib—kidney cancer	0.000349	0.00167	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000348	0.00166	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000344	0.00165	CcSEcCtD
Saxagliptin—Nausea—Pazopanib—kidney cancer	0.000344	0.00165	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000343	0.00164	CcSEcCtD
Saxagliptin—Fatigue—Sorafenib—kidney cancer	0.000342	0.00164	CcSEcCtD
Saxagliptin—Hypersensitivity—Vinblastine—kidney cancer	0.000338	0.00162	CcSEcCtD
Saxagliptin—Myalgia—Vincristine—kidney cancer	0.000337	0.00161	CcSEcCtD
Saxagliptin—Hypersensitivity—Everolimus—kidney cancer	0.000337	0.00161	CcSEcCtD
Saxagliptin—Dyspepsia—Sunitinib—kidney cancer	0.000336	0.00161	CcSEcCtD
Saxagliptin—Infestation NOS—Capecitabine—kidney cancer	0.00033	0.00158	CcSEcCtD
Saxagliptin—Infestation—Capecitabine—kidney cancer	0.00033	0.00158	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00033	0.00158	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000329	0.00158	CcSEcCtD
Saxagliptin—Asthenia—Vinblastine—kidney cancer	0.000329	0.00158	CcSEcCtD
Saxagliptin—Fatigue—Sunitinib—kidney cancer	0.000329	0.00158	CcSEcCtD
Saxagliptin—Asthenia—Everolimus—kidney cancer	0.000328	0.00157	CcSEcCtD
Saxagliptin—Immune system disorder—Paclitaxel—kidney cancer	0.000326	0.00156	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Sorafenib—kidney cancer	0.000324	0.00155	CcSEcCtD
Saxagliptin—Pruritus—Everolimus—kidney cancer	0.000323	0.00155	CcSEcCtD
Saxagliptin—Anaphylactic shock—Vincristine—kidney cancer	0.000323	0.00155	CcSEcCtD
Saxagliptin—Infection—Vincristine—kidney cancer	0.000321	0.00154	CcSEcCtD
Saxagliptin—Urinary tract infection—Capecitabine—kidney cancer	0.000321	0.00154	CcSEcCtD
Saxagliptin—Arthralgia—Gemcitabine—kidney cancer	0.00032	0.00153	CcSEcCtD
Saxagliptin—Myalgia—Gemcitabine—kidney cancer	0.00032	0.00153	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000317	0.00152	CcSEcCtD
Saxagliptin—Asthenia—Erlotinib—kidney cancer	0.000316	0.00151	CcSEcCtD
Saxagliptin—Thrombocytopenia—Vincristine—kidney cancer	0.000316	0.00151	CcSEcCtD
Saxagliptin—Urticaria—Sorafenib—kidney cancer	0.000315	0.00151	CcSEcCtD
Saxagliptin—Malnutrition—Paclitaxel—kidney cancer	0.000314	0.0015	CcSEcCtD
Saxagliptin—Abdominal pain—Sorafenib—kidney cancer	0.000314	0.0015	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Sunitinib—kidney cancer	0.000312	0.00149	CcSEcCtD
Saxagliptin—Pruritus—Erlotinib—kidney cancer	0.000312	0.00149	CcSEcCtD
Saxagliptin—Fatigue—Dactinomycin—kidney cancer	0.000312	0.00149	CcSEcCtD
Saxagliptin—Flatulence—Paclitaxel—kidney cancer	0.00031	0.00148	CcSEcCtD
Saxagliptin—Anaphylactic shock—Gemcitabine—kidney cancer	0.000306	0.00147	CcSEcCtD
Saxagliptin—Infection—Gemcitabine—kidney cancer	0.000304	0.00146	CcSEcCtD
Saxagliptin—Dizziness—Vinblastine—kidney cancer	0.000303	0.00145	CcSEcCtD
Saxagliptin—Dizziness—Everolimus—kidney cancer	0.000302	0.00145	CcSEcCtD
Saxagliptin—Abdominal pain—Sunitinib—kidney cancer	0.000302	0.00144	CcSEcCtD
Saxagliptin—Thrombocytopenia—Gemcitabine—kidney cancer	0.0003	0.00144	CcSEcCtD
Saxagliptin—Skin disorder—Gemcitabine—kidney cancer	0.000298	0.00142	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000296	0.00141	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000294	0.00141	CcSEcCtD
Saxagliptin—Hypersensitivity—Sorafenib—kidney cancer	0.000292	0.0014	CcSEcCtD
Saxagliptin—Oedema peripheral—Capecitabine—kidney cancer	0.000292	0.0014	CcSEcCtD
Saxagliptin—Vomiting—Vinblastine—kidney cancer	0.000292	0.0014	CcSEcCtD
Saxagliptin—Dizziness—Erlotinib—kidney cancer	0.000292	0.0014	CcSEcCtD
Saxagliptin—Vomiting—Everolimus—kidney cancer	0.000291	0.00139	CcSEcCtD
Saxagliptin—Rash—Everolimus—kidney cancer	0.000288	0.00138	CcSEcCtD
Saxagliptin—Dermatitis—Everolimus—kidney cancer	0.000288	0.00138	CcSEcCtD
Saxagliptin—Headache—Vinblastine—kidney cancer	0.000287	0.00138	CcSEcCtD
Saxagliptin—Angioedema—Paclitaxel—kidney cancer	0.000287	0.00137	CcSEcCtD
Saxagliptin—Purpura—Doxorubicin—kidney cancer	0.000286	0.00137	CcSEcCtD
Saxagliptin—Headache—Everolimus—kidney cancer	0.000286	0.00137	CcSEcCtD
Saxagliptin—Abdominal pain—Dactinomycin—kidney cancer	0.000286	0.00137	CcSEcCtD
Saxagliptin—Asthenia—Sorafenib—kidney cancer	0.000285	0.00136	CcSEcCtD
Saxagliptin—Hypoglycaemia—Doxorubicin—kidney cancer	0.000283	0.00135	CcSEcCtD
Saxagliptin—Hypersensitivity—Sunitinib—kidney cancer	0.000281	0.00135	CcSEcCtD
Saxagliptin—Pruritus—Sorafenib—kidney cancer	0.000281	0.00134	CcSEcCtD
Saxagliptin—Vomiting—Erlotinib—kidney cancer	0.00028	0.00134	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000279	0.00134	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Vincristine—kidney cancer	0.000279	0.00133	CcSEcCtD
Saxagliptin—Fatigue—Vincristine—kidney cancer	0.000278	0.00133	CcSEcCtD
Saxagliptin—Rash—Erlotinib—kidney cancer	0.000278	0.00133	CcSEcCtD
Saxagliptin—Dermatitis—Erlotinib—kidney cancer	0.000278	0.00133	CcSEcCtD
Saxagliptin—Headache—Erlotinib—kidney cancer	0.000276	0.00132	CcSEcCtD
Saxagliptin—Asthenia—Sunitinib—kidney cancer	0.000274	0.00131	CcSEcCtD
Saxagliptin—Nausea—Vinblastine—kidney cancer	0.000273	0.0013	CcSEcCtD
Saxagliptin—Nausea—Everolimus—kidney cancer	0.000272	0.0013	CcSEcCtD
Saxagliptin—Pruritus—Sunitinib—kidney cancer	0.00027	0.00129	CcSEcCtD
Saxagliptin—Immune system disorder—Capecitabine—kidney cancer	0.000268	0.00128	CcSEcCtD
Saxagliptin—Myalgia—Paclitaxel—kidney cancer	0.000268	0.00128	CcSEcCtD
Saxagliptin—Arthralgia—Paclitaxel—kidney cancer	0.000268	0.00128	CcSEcCtD
Saxagliptin—Face oedema—Doxorubicin—kidney cancer	0.000267	0.00128	CcSEcCtD
Saxagliptin—Hypersensitivity—Dactinomycin—kidney cancer	0.000266	0.00127	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000266	0.00127	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000265	0.00127	CcSEcCtD
Saxagliptin—Fatigue—Gemcitabine—kidney cancer	0.000264	0.00126	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Vincristine—kidney cancer	0.000264	0.00126	CcSEcCtD
Saxagliptin—Dizziness—Sorafenib—kidney cancer	0.000262	0.00126	CcSEcCtD
Saxagliptin—Nausea—Erlotinib—kidney cancer	0.000262	0.00125	CcSEcCtD
Saxagliptin—Asthenia—Dactinomycin—kidney cancer	0.000259	0.00124	CcSEcCtD
Saxagliptin—Blood creatinine increased—Doxorubicin—kidney cancer	0.000259	0.00124	CcSEcCtD
Saxagliptin—Malnutrition—Capecitabine—kidney cancer	0.000258	0.00123	CcSEcCtD
Saxagliptin—Anaphylactic shock—Paclitaxel—kidney cancer	0.000257	0.00123	CcSEcCtD
Saxagliptin—Abdominal pain—Vincristine—kidney cancer	0.000255	0.00122	CcSEcCtD
Saxagliptin—Infection—Paclitaxel—kidney cancer	0.000255	0.00122	CcSEcCtD
Saxagliptin—Flatulence—Capecitabine—kidney cancer	0.000254	0.00122	CcSEcCtD
Saxagliptin—Dizziness—Sunitinib—kidney cancer	0.000253	0.00121	CcSEcCtD
Saxagliptin—Vomiting—Sorafenib—kidney cancer	0.000252	0.00121	CcSEcCtD
Saxagliptin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000251	0.0012	CcSEcCtD
Saxagliptin—Rash—Sorafenib—kidney cancer	0.00025	0.0012	CcSEcCtD
Saxagliptin—Dermatitis—Sorafenib—kidney cancer	0.00025	0.0012	CcSEcCtD
Saxagliptin—Skin disorder—Paclitaxel—kidney cancer	0.000249	0.00119	CcSEcCtD
Saxagliptin—Headache—Sorafenib—kidney cancer	0.000249	0.00119	CcSEcCtD
Saxagliptin—Nasopharyngitis—Doxorubicin—kidney cancer	0.000247	0.00118	CcSEcCtD
Saxagliptin—Gastritis—Doxorubicin—kidney cancer	0.000244	0.00117	CcSEcCtD
Saxagliptin—Vomiting—Sunitinib—kidney cancer	0.000243	0.00116	CcSEcCtD
Saxagliptin—Rash—Sunitinib—kidney cancer	0.000241	0.00115	CcSEcCtD
Saxagliptin—Dermatitis—Sunitinib—kidney cancer	0.000241	0.00115	CcSEcCtD
Saxagliptin—Headache—Sunitinib—kidney cancer	0.000239	0.00114	CcSEcCtD
Saxagliptin—Hypersensitivity—Vincristine—kidney cancer	0.000238	0.00114	CcSEcCtD
Saxagliptin—Nausea—Sorafenib—kidney cancer	0.000236	0.00113	CcSEcCtD
Saxagliptin—Pancreatitis—Doxorubicin—kidney cancer	0.000234	0.00112	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000234	0.00112	CcSEcCtD
Saxagliptin—Asthenia—Vincristine—kidney cancer	0.000232	0.00111	CcSEcCtD
Saxagliptin—Vomiting—Dactinomycin—kidney cancer	0.00023	0.0011	CcSEcCtD
Saxagliptin—Rash—Dactinomycin—kidney cancer	0.000228	0.00109	CcSEcCtD
Saxagliptin—Nausea—Sunitinib—kidney cancer	0.000227	0.00109	CcSEcCtD
Saxagliptin—Dyspepsia—Paclitaxel—kidney cancer	0.000226	0.00108	CcSEcCtD
Saxagliptin—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000222	0.00106	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000221	0.00106	CcSEcCtD
Saxagliptin—Fatigue—Paclitaxel—kidney cancer	0.000221	0.00106	CcSEcCtD
Saxagliptin—Asthenia—Gemcitabine—kidney cancer	0.00022	0.00105	CcSEcCtD
Saxagliptin—Arthralgia—Capecitabine—kidney cancer	0.00022	0.00105	CcSEcCtD
Saxagliptin—Myalgia—Capecitabine—kidney cancer	0.00022	0.00105	CcSEcCtD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000218	0.00104	CcSEcCtD
Saxagliptin—Pruritus—Gemcitabine—kidney cancer	0.000217	0.00104	CcSEcCtD
Saxagliptin—Nausea—Dactinomycin—kidney cancer	0.000215	0.00103	CcSEcCtD
Saxagliptin—Dizziness—Vincristine—kidney cancer	0.000214	0.00102	CcSEcCtD
Saxagliptin—Infestation NOS—Doxorubicin—kidney cancer	0.000213	0.00102	CcSEcCtD
Saxagliptin—Infestation—Doxorubicin—kidney cancer	0.000213	0.00102	CcSEcCtD
Saxagliptin—DPP4—Metabolism of proteins—HSPA9—kidney cancer	0.00021	0.00786	CbGpPWpGaD
Saxagliptin—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00021	0.001	CcSEcCtD
Saxagliptin—Infection—Capecitabine—kidney cancer	0.000209	0.001	CcSEcCtD
Saxagliptin—Urinary tract infection—Doxorubicin—kidney cancer	0.000207	0.00099	CcSEcCtD
Saxagliptin—ABCC1—S1P1 pathway—PTGS2—kidney cancer	0.000207	0.00773	CbGpPWpGaD
Saxagliptin—Thrombocytopenia—Capecitabine—kidney cancer	0.000206	0.000986	CcSEcCtD
Saxagliptin—Vomiting—Vincristine—kidney cancer	0.000205	0.000983	CcSEcCtD
Saxagliptin—Skin disorder—Capecitabine—kidney cancer	0.000204	0.000978	CcSEcCtD
Saxagliptin—Urticaria—Paclitaxel—kidney cancer	0.000204	0.000975	CcSEcCtD
Saxagliptin—Rash—Vincristine—kidney cancer	0.000204	0.000974	CcSEcCtD
Saxagliptin—Dermatitis—Vincristine—kidney cancer	0.000203	0.000973	CcSEcCtD
Saxagliptin—Abdominal pain—Paclitaxel—kidney cancer	0.000203	0.00097	CcSEcCtD
Saxagliptin—Headache—Vincristine—kidney cancer	0.000202	0.000968	CcSEcCtD
Saxagliptin—CYP3A5—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000202	0.00756	CbGpPWpGaD
Saxagliptin—Sinusitis—Doxorubicin—kidney cancer	0.0002	0.000955	CcSEcCtD
Saxagliptin—CYP3A5—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000199	0.00746	CbGpPWpGaD
Saxagliptin—Vomiting—Gemcitabine—kidney cancer	0.000195	0.000932	CcSEcCtD
Saxagliptin—CYP3A5—Biological oxidations—ACY1—kidney cancer	0.000193	0.00723	CbGpPWpGaD
Saxagliptin—Rash—Gemcitabine—kidney cancer	0.000193	0.000924	CcSEcCtD
Saxagliptin—Dermatitis—Gemcitabine—kidney cancer	0.000193	0.000924	CcSEcCtD
Saxagliptin—Headache—Gemcitabine—kidney cancer	0.000192	0.000918	CcSEcCtD
Saxagliptin—Nausea—Vincristine—kidney cancer	0.000192	0.000918	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000192	0.000918	CcSEcCtD
Saxagliptin—Hypersensitivity—Paclitaxel—kidney cancer	0.000189	0.000904	CcSEcCtD
Saxagliptin—Oedema peripheral—Doxorubicin—kidney cancer	0.000188	0.0009	CcSEcCtD
Saxagliptin—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.000188	0.00701	CbGpPWpGaD
Saxagliptin—Dyspepsia—Capecitabine—kidney cancer	0.000185	0.000887	CcSEcCtD
Saxagliptin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000185	0.00692	CbGpPWpGaD
Saxagliptin—Asthenia—Paclitaxel—kidney cancer	0.000184	0.000881	CcSEcCtD
Saxagliptin—Nausea—Gemcitabine—kidney cancer	0.000182	0.000871	CcSEcCtD
Saxagliptin—SLCO4C1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000182	0.0068	CbGpPWpGaD
Saxagliptin—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000182	0.00087	CcSEcCtD
Saxagliptin—Fatigue—Capecitabine—kidney cancer	0.000181	0.000868	CcSEcCtD
Saxagliptin—Pruritus—Paclitaxel—kidney cancer	0.000181	0.000868	CcSEcCtD
Saxagliptin—SLCO4C1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000176	0.00657	CbGpPWpGaD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000175	0.00656	CbGpPWpGaD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000175	0.00656	CbGpPWpGaD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000175	0.00656	CbGpPWpGaD
Saxagliptin—Immune system disorder—Doxorubicin—kidney cancer	0.000173	0.000825	CcSEcCtD
Saxagliptin—Gastrointestinal pain—Capecitabine—kidney cancer	0.000172	0.000824	CcSEcCtD
Saxagliptin—DPP4—Metabolism of proteins—MUC4—kidney cancer	0.000171	0.00641	CbGpPWpGaD
Saxagliptin—Dizziness—Paclitaxel—kidney cancer	0.00017	0.000812	CcSEcCtD
Saxagliptin—Urticaria—Capecitabine—kidney cancer	0.000167	0.0008	CcSEcCtD
Saxagliptin—Abdominal pain—Capecitabine—kidney cancer	0.000166	0.000796	CcSEcCtD
Saxagliptin—Malnutrition—Doxorubicin—kidney cancer	0.000166	0.000796	CcSEcCtD
Saxagliptin—Flatulence—Doxorubicin—kidney cancer	0.000164	0.000784	CcSEcCtD
Saxagliptin—Vomiting—Paclitaxel—kidney cancer	0.000163	0.00078	CcSEcCtD
Saxagliptin—DPP4—Metabolism of proteins—ST3GAL2—kidney cancer	0.000163	0.00609	CbGpPWpGaD
Saxagliptin—ABCC1—S1P1 pathway—VEGFA—kidney cancer	0.000163	0.00609	CbGpPWpGaD
Saxagliptin—Rash—Paclitaxel—kidney cancer	0.000162	0.000774	CcSEcCtD
Saxagliptin—Dermatitis—Paclitaxel—kidney cancer	0.000162	0.000773	CcSEcCtD
Saxagliptin—Headache—Paclitaxel—kidney cancer	0.000161	0.000769	CcSEcCtD
Saxagliptin—ABCC1—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.00016	0.00599	CbGpPWpGaD
Saxagliptin—DPP4—Peptide hormone metabolism—CTNNB1—kidney cancer	0.000159	0.00596	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—EEF2—kidney cancer	0.000159	0.00596	CbGpPWpGaD
Saxagliptin—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000157	0.00586	CbGpPWpGaD
Saxagliptin—Hypersensitivity—Capecitabine—kidney cancer	0.000155	0.000742	CcSEcCtD
Saxagliptin—ABCC1—S1P1 pathway—MAPK3—kidney cancer	0.000154	0.00576	CbGpPWpGaD
Saxagliptin—Nausea—Paclitaxel—kidney cancer	0.000152	0.000729	CcSEcCtD
Saxagliptin—Asthenia—Capecitabine—kidney cancer	0.000151	0.000723	CcSEcCtD
Saxagliptin—Pruritus—Capecitabine—kidney cancer	0.000149	0.000713	CcSEcCtD
Saxagliptin—ABCC1—S1P1 pathway—MAPK1—kidney cancer	0.000146	0.00548	CbGpPWpGaD
Saxagliptin—SLC22A8—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000145	0.00542	CbGpPWpGaD
Saxagliptin—Myalgia—Doxorubicin—kidney cancer	0.000142	0.000677	CcSEcCtD
Saxagliptin—Arthralgia—Doxorubicin—kidney cancer	0.000142	0.000677	CcSEcCtD
Saxagliptin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—kidney cancer	0.000142	0.00529	CbGpPWpGaD
Saxagliptin—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000141	0.00529	CbGpPWpGaD
Saxagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000141	0.000673	CcSEcCtD
Saxagliptin—Dizziness—Capecitabine—kidney cancer	0.000139	0.000666	CcSEcCtD
Saxagliptin—Anaphylactic shock—Doxorubicin—kidney cancer	0.000136	0.000649	CcSEcCtD
Saxagliptin—Infection—Doxorubicin—kidney cancer	0.000135	0.000645	CcSEcCtD
Saxagliptin—Vomiting—Capecitabine—kidney cancer	0.000134	0.00064	CcSEcCtD
Saxagliptin—Thrombocytopenia—Doxorubicin—kidney cancer	0.000133	0.000636	CcSEcCtD
Saxagliptin—Rash—Capecitabine—kidney cancer	0.000133	0.000635	CcSEcCtD
Saxagliptin—Dermatitis—Capecitabine—kidney cancer	0.000133	0.000635	CcSEcCtD
Saxagliptin—Headache—Capecitabine—kidney cancer	0.000132	0.000631	CcSEcCtD
Saxagliptin—Skin disorder—Doxorubicin—kidney cancer	0.000132	0.000631	CcSEcCtD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000128	0.00479	CbGpPWpGaD
Saxagliptin—Nausea—Capecitabine—kidney cancer	0.000125	0.000598	CcSEcCtD
Saxagliptin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000124	0.000592	CcSEcCtD
Saxagliptin—DPP4—Metabolism of proteins—MME—kidney cancer	0.000122	0.00457	CbGpPWpGaD
Saxagliptin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000121	0.00452	CbGpPWpGaD
Saxagliptin—Dyspepsia—Doxorubicin—kidney cancer	0.000119	0.000572	CcSEcCtD
Saxagliptin—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000117	0.000561	CcSEcCtD
Saxagliptin—Fatigue—Doxorubicin—kidney cancer	0.000117	0.00056	CcSEcCtD
Saxagliptin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000117	0.00437	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—HSPD1—kidney cancer	0.000113	0.00424	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—RPL14—kidney cancer	0.000113	0.00424	CbGpPWpGaD
Saxagliptin—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.000112	0.00419	CbGpPWpGaD
Saxagliptin—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000111	0.000531	CcSEcCtD
Saxagliptin—CYP3A5—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.00011	0.00411	CbGpPWpGaD
Saxagliptin—Urticaria—Doxorubicin—kidney cancer	0.000108	0.000516	CcSEcCtD
Saxagliptin—Abdominal pain—Doxorubicin—kidney cancer	0.000107	0.000513	CcSEcCtD
Saxagliptin—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.000106	0.00398	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—ALDH1A1—kidney cancer	0.000106	0.00396	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000102	0.00383	CbGpPWpGaD
Saxagliptin—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000102	0.00381	CbGpPWpGaD
Saxagliptin—Hypersensitivity—Doxorubicin—kidney cancer	0.0001	0.000478	CcSEcCtD
Saxagliptin—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	9.77e-05	0.00365	CbGpPWpGaD
Saxagliptin—Asthenia—Doxorubicin—kidney cancer	9.74e-05	0.000466	CcSEcCtD
Saxagliptin—Pruritus—Doxorubicin—kidney cancer	9.6e-05	0.000459	CcSEcCtD
Saxagliptin—ABCC1—Arachidonic acid metabolism—PTGS2—kidney cancer	9.53e-05	0.00356	CbGpPWpGaD
Saxagliptin—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	9.4e-05	0.00351	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—ACHE—kidney cancer	9.36e-05	0.0035	CbGpPWpGaD
Saxagliptin—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	9.27e-05	0.00347	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—EIF4EBP1—kidney cancer	9.25e-05	0.00346	CbGpPWpGaD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.24e-05	0.00346	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—ACY1—kidney cancer	8.99e-05	0.00336	CbGpPWpGaD
Saxagliptin—Dizziness—Doxorubicin—kidney cancer	8.97e-05	0.000429	CcSEcCtD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.93e-05	0.00334	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—PAX6—kidney cancer	8.91e-05	0.00333	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—CTSD—kidney cancer	8.86e-05	0.00331	CbGpPWpGaD
Saxagliptin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	8.73e-05	0.00326	CbGpPWpGaD
Saxagliptin—Vomiting—Doxorubicin—kidney cancer	8.63e-05	0.000413	CcSEcCtD
Saxagliptin—CYP3A5—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	8.61e-05	0.00322	CbGpPWpGaD
Saxagliptin—Rash—Doxorubicin—kidney cancer	8.56e-05	0.000409	CcSEcCtD
Saxagliptin—Dermatitis—Doxorubicin—kidney cancer	8.55e-05	0.000409	CcSEcCtD
Saxagliptin—Headache—Doxorubicin—kidney cancer	8.5e-05	0.000407	CcSEcCtD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.16e-05	0.00305	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—BCHE—kidney cancer	8.15e-05	0.00305	CbGpPWpGaD
Saxagliptin—Nausea—Doxorubicin—kidney cancer	8.06e-05	0.000386	CcSEcCtD
Saxagliptin—SLC22A8—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	7.64e-05	0.00286	CbGpPWpGaD
Saxagliptin—SLC22A8—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	7.38e-05	0.00276	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—ANXA2—kidney cancer	7.36e-05	0.00275	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—ATP7B—kidney cancer	7.36e-05	0.00275	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—SLC5A3—kidney cancer	7.36e-05	0.00275	CbGpPWpGaD
Saxagliptin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	7.29e-05	0.00273	CbGpPWpGaD
Saxagliptin—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	7.08e-05	0.00265	CbGpPWpGaD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.05e-05	0.00264	CbGpPWpGaD
Saxagliptin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	6.94e-05	0.0026	CbGpPWpGaD
Saxagliptin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.51e-05	0.00243	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—IGF2—kidney cancer	6.31e-05	0.00236	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—GSTT1—kidney cancer	6.22e-05	0.00233	CbGpPWpGaD
Saxagliptin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—kidney cancer	6.12e-05	0.00229	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—ATP7B—kidney cancer	5.88e-05	0.0022	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—ANXA2—kidney cancer	5.88e-05	0.0022	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	5.88e-05	0.0022	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—PTGS1—kidney cancer	5.83e-05	0.00218	CbGpPWpGaD
Saxagliptin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.28e-05	0.00197	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ACY1—kidney cancer	5.24e-05	0.00196	CbGpPWpGaD
Saxagliptin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	5.1e-05	0.00191	CbGpPWpGaD
Saxagliptin—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	5.02e-05	0.00188	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CCBL1—kidney cancer	5.01e-05	0.00187	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	4.92e-05	0.00184	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—AMER1—kidney cancer	4.53e-05	0.00169	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.47e-05	0.00167	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PDHB—kidney cancer	4.46e-05	0.00167	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—GSTP1—kidney cancer	4.31e-05	0.00161	CbGpPWpGaD
Saxagliptin—CYP3A5—Metapathway biotransformation—GSTP1—kidney cancer	4.25e-05	0.00159	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—POMC—kidney cancer	4.21e-05	0.00158	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CCBL1—kidney cancer	4.19e-05	0.00157	CbGpPWpGaD
Saxagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	4.06e-05	0.00152	CbGpPWpGaD
Saxagliptin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	4e-05	0.0015	CbGpPWpGaD
Saxagliptin—SLCO4C1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.99e-05	0.00149	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—GSTM1—kidney cancer	3.96e-05	0.00148	CbGpPWpGaD
Saxagliptin—CYP3A5—Metapathway biotransformation—GSTM1—kidney cancer	3.91e-05	0.00146	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.88e-05	0.00145	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—GPC3—kidney cancer	3.79e-05	0.00142	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.79e-05	0.00142	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—CYP1A1—kidney cancer	3.76e-05	0.00141	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.75e-05	0.0014	CbGpPWpGaD
Saxagliptin—CYP3A5—Metapathway biotransformation—CYP1A1—kidney cancer	3.71e-05	0.00139	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PPAT—kidney cancer	3.63e-05	0.00136	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GLIPR1—kidney cancer	3.63e-05	0.00136	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.59e-05	0.00134	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.55e-05	0.00133	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—ST3GAL2—kidney cancer	3.51e-05	0.00131	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—FH—kidney cancer	3.38e-05	0.00126	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—APRT—kidney cancer	3.38e-05	0.00126	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ACY1—kidney cancer	3.31e-05	0.00124	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.3e-05	0.00124	CbGpPWpGaD
Saxagliptin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.29e-05	0.00123	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PGK1—kidney cancer	3.29e-05	0.00123	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—SLC5A3—kidney cancer	3.29e-05	0.00123	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—LDHB—kidney cancer	3.23e-05	0.00121	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—SFRP2—kidney cancer	3.23e-05	0.00121	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GPC3—kidney cancer	3.18e-05	0.00119	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.1e-05	0.00116	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CA2—kidney cancer	3.09e-05	0.00116	CbGpPWpGaD
Saxagliptin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	3.03e-05	0.00113	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ALAD—kidney cancer	3.01e-05	0.00113	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—TCEB2—kidney cancer	3.01e-05	0.00113	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—TCEB1—kidney cancer	3.01e-05	0.00113	CbGpPWpGaD
Saxagliptin—DPP4—Metabolism of proteins—CTNNB1—kidney cancer	3.01e-05	0.00112	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3e-05	0.00112	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.96e-05	0.00111	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ST3GAL2—kidney cancer	2.94e-05	0.0011	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.89e-05	0.00108	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ALDH1A1—kidney cancer	2.87e-05	0.00107	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PDHB—kidney cancer	2.81e-05	0.00105	CbGpPWpGaD
Saxagliptin—CYP3A5—Biological oxidations—POMC—kidney cancer	2.8e-05	0.00105	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—SLC5A3—kidney cancer	2.75e-05	0.00103	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PGK1—kidney cancer	2.75e-05	0.00103	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.71e-05	0.00101	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—LDHB—kidney cancer	2.7e-05	0.00101	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CCBL1—kidney cancer	2.64e-05	0.000988	CbGpPWpGaD
Saxagliptin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.45e-05	0.000917	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—RPL14—kidney cancer	2.44e-05	0.000914	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.37e-05	0.000885	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CA9—kidney cancer	2.34e-05	0.000876	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PPAT—kidney cancer	2.29e-05	0.000857	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GLIPR1—kidney cancer	2.29e-05	0.000857	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.29e-05	0.000856	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—ITPR2—kidney cancer	2.21e-05	0.000827	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—FH—kidney cancer	2.13e-05	0.000797	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—APRT—kidney cancer	2.13e-05	0.000797	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.01e-05	0.00075	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GPC3—kidney cancer	2e-05	0.000749	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CRABP1—kidney cancer	1.99e-05	0.000745	CbGpPWpGaD
Saxagliptin—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.98e-05	0.00074	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CA2—kidney cancer	1.95e-05	0.000729	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ALAD—kidney cancer	1.9e-05	0.00071	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ST3GAL2—kidney cancer	1.85e-05	0.000693	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PSMD7—kidney cancer	1.85e-05	0.000693	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ITPR2—kidney cancer	1.85e-05	0.000692	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.84e-05	0.000689	CbGpPWpGaD
Saxagliptin—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.82e-05	0.00068	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ALDH1A1—kidney cancer	1.81e-05	0.000677	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.75e-05	0.000653	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PGK1—kidney cancer	1.74e-05	0.000649	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.74e-05	0.000649	CbGpPWpGaD
Saxagliptin—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.72e-05	0.000645	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.71e-05	0.000638	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—LDHB—kidney cancer	1.7e-05	0.000637	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ACHE—kidney cancer	1.69e-05	0.000631	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GSTT1—kidney cancer	1.69e-05	0.000631	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—SLC2A1—kidney cancer	1.68e-05	0.000627	CbGpPWpGaD
Saxagliptin—SLC22A8—Transmembrane transport of small molecules—RAF1—kidney cancer	1.67e-05	0.000626	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—JUNB—kidney cancer	1.66e-05	0.000622	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—SCARB1—kidney cancer	1.6e-05	0.000598	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PTGS1—kidney cancer	1.58e-05	0.000592	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PSMD7—kidney cancer	1.55e-05	0.00058	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ACY1—kidney cancer	1.54e-05	0.000575	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CA9—kidney cancer	1.48e-05	0.000552	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—BCHE—kidney cancer	1.47e-05	0.00055	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—SLC5A5—kidney cancer	1.45e-05	0.000543	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—SLC2A1—kidney cancer	1.4e-05	0.000525	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.36e-05	0.000509	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CDKN2B—kidney cancer	1.35e-05	0.000506	CbGpPWpGaD
Saxagliptin—ABCC1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.34e-05	0.0005	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PDHB—kidney cancer	1.31e-05	0.000489	CbGpPWpGaD
Saxagliptin—CYP3A4—Biological oxidations—POMC—kidney cancer	1.3e-05	0.000487	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CRABP1—kidney cancer	1.26e-05	0.00047	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CCBL1—kidney cancer	1.23e-05	0.00046	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.19e-05	0.000444	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GSTP1—kidney cancer	1.17e-05	0.000438	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ITPR2—kidney cancer	1.17e-05	0.000437	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—ABCB1—kidney cancer	1.11e-05	0.000414	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—HIF1A—kidney cancer	1.08e-05	0.000405	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—TSC2—kidney cancer	1.08e-05	0.000404	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—GSTM1—kidney cancer	1.08e-05	0.000402	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PPAT—kidney cancer	1.07e-05	0.000398	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.07e-05	0.000398	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ACHE—kidney cancer	1.06e-05	0.000398	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTT1—kidney cancer	1.06e-05	0.000398	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—CYP1A1—kidney cancer	1.02e-05	0.000381	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—SCARB1—kidney cancer	1.01e-05	0.000377	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PTGS1—kidney cancer	9.97e-06	0.000373	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—FH—kidney cancer	9.9e-06	0.00037	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—APRT—kidney cancer	9.9e-06	0.00037	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PSMD7—kidney cancer	9.78e-06	0.000366	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—APC—kidney cancer	9.53e-06	0.000357	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—KIT—kidney cancer	9.53e-06	0.000357	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GPC3—kidney cancer	9.31e-06	0.000348	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—BCHE—kidney cancer	9.27e-06	0.000347	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—SLC5A5—kidney cancer	9.16e-06	0.000343	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CA2—kidney cancer	9.06e-06	0.000339	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—BRAF—kidney cancer	8.96e-06	0.000335	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—SLC2A1—kidney cancer	8.85e-06	0.000331	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ALAD—kidney cancer	8.83e-06	0.00033	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.62e-06	0.000322	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.42e-06	0.000315	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.38e-06	0.000313	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PGK1—kidney cancer	8.07e-06	0.000302	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SLC5A3—kidney cancer	8.07e-06	0.000302	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—LDHB—kidney cancer	7.92e-06	0.000296	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—POMC—kidney cancer	7.6e-06	0.000284	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—RAF1—kidney cancer	7.48e-06	0.00028	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—ERBB2—kidney cancer	7.4e-06	0.000277	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTP1—kidney cancer	7.38e-06	0.000276	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—MTOR—kidney cancer	7.31e-06	0.000273	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CD4—kidney cancer	7.29e-06	0.000273	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PTGS2—kidney cancer	7.24e-06	0.000271	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—ABCB1—kidney cancer	6.98e-06	0.000261	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CA9—kidney cancer	6.86e-06	0.000257	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CDKN1B—kidney cancer	6.86e-06	0.000256	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—GSTM1—kidney cancer	6.78e-06	0.000254	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—CTNNB1—kidney cancer	6.48e-06	0.000242	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—CYP1A1—kidney cancer	6.43e-06	0.00024	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PTEN—kidney cancer	6.31e-06	0.000236	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PTGS2—kidney cancer	6.06e-06	0.000227	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CRABP1—kidney cancer	5.84e-06	0.000218	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ITPR2—kidney cancer	5.43e-06	0.000203	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—MAPK3—kidney cancer	5.39e-06	0.000202	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PTEN—kidney cancer	5.29e-06	0.000198	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—MYC—kidney cancer	5.25e-06	0.000196	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—MAPK1—kidney cancer	5.13e-06	0.000192	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ACHE—kidney cancer	4.95e-06	0.000185	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTT1—kidney cancer	4.95e-06	0.000185	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—KRAS—kidney cancer	4.85e-06	0.000181	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—POMC—kidney cancer	4.79e-06	0.000179	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SCARB1—kidney cancer	4.68e-06	0.000175	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PTGS1—kidney cancer	4.64e-06	0.000173	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PSMD7—kidney cancer	4.55e-06	0.00017	CbGpPWpGaD
Saxagliptin—ABCC1—Disease—PIK3CA—kidney cancer	4.45e-06	0.000167	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—BCHE—kidney cancer	4.31e-06	0.000161	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.26e-06	0.000159	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.11e-06	0.000154	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PTGS2—kidney cancer	3.82e-06	0.000143	CbGpPWpGaD
Saxagliptin—ABCC1—Metabolism—PIK3CA—kidney cancer	3.73e-06	0.000139	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTP1—kidney cancer	3.43e-06	0.000128	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PTEN—kidney cancer	3.33e-06	0.000125	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—ABCB1—kidney cancer	3.25e-06	0.000121	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—GSTM1—kidney cancer	3.15e-06	0.000118	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.99e-06	0.000112	CbGpPWpGaD
Saxagliptin—CYP3A5—Metabolism—PIK3CA—kidney cancer	2.35e-06	8.79e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—POMC—kidney cancer	2.23e-06	8.33e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PTGS2—kidney cancer	1.78e-06	6.65e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PTEN—kidney cancer	1.55e-06	5.8e-05	CbGpPWpGaD
Saxagliptin—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.09e-06	4.09e-05	CbGpPWpGaD
